Mechanical and microstructural investigations of tungsten and doped tungsten materials produced via powder injection molding

The physical properties of tungsten such as the high melting point of 3420°C, the high strength and thermal conductivity, the low thermal expansion and low erosion rate make this material attractive as a plasma facing material. However, the manufacturing of such tungsten parts by mechanical machining such as milling and turning is extremely costly and time intensive because this material is very hard and brittle. Powder Injection Molding (PIM) as special process allows the mass production of components, the joining of different materials without brazing and the creation of composite and prototype materials, and is an ideal tool for scientific investigations. This contribution describes the characterization and analyses of prototype materials produced via PIM. The investigation of the pure tungsten and oxide or carbide doped tungsten materials comprises the microstructure examination, element allocation, texture analyses, and mechanical testing via four-point bend (4-PB). Furthermore, the different materials were characterized by high heat flux (HHF) tests applying transient thermal loads at different base temperatures to address thermal shock and thermal fatigue performance. Additionally, HHF investigations provide information about the thermo-mechanical behavior to extreme steady state thermal loading and measurements of the thermal conductivity as well as oxidation tests were done. Post mortem analyses are performed quantifying and qualifying the occurring damage with respect to reference tungsten grades by metallographic and microscopical means

Ionic liquids at electrified interfaces

Until recently, “room-temperature” (<100–150 °C) liquid-state electrochemistry was mostly electrochemistry of diluted electrolytes(1)–(4) where dissolved salt ions were surrounded by a considerable amount of solvent molecules. Highly concentrated liquid electrolytes were mostly considered in the narrow (albeit important) niche of high-temperature electrochemistry of molten inorganic salts(5-9) and in the even narrower niche of “first-generation” room temperature ionic liquids, RTILs (such as chloro-aluminates and alkylammonium nitrates).(10-14) The situation has changed dramatically in the 2000s after the discovery of new moisture- and temperature-stable RTILs.(15, 16) These days, the “later generation” RTILs attracted wide attention within the electrochemical community.(17-31) Indeed, RTILs, as a class of compounds, possess a unique combination of properties (high charge density, electrochemical stability, low/negligible volatility, tunable polarity, etc.) that make them very attractive substances from fundamental and application points of view.(32-38) Most importantly, they can mix with each other in “cocktails” of one’s choice to acquire the desired properties (e.g., wider temperature range of the liquid phase(39, 40)) and can serve as almost “universal” solvents.(37, 41, 42) It is worth noting here one of the advantages of RTILs as compared to their high-temperature molten salt (HTMS)(43) “sister-systems”.(44) In RTILs the dissolved molecules are not imbedded in a harsh high temperature environment which could be destructive for many classes of fragile (organic) molecules

Classification strategies in machine learning techniques predicting regime changes and durations in the Lorenz system

In this paper, we use machine learning strategies aiming to predict chaotic time series obtained from the Lorenz system. Such strategies prove to be successful in predicting the evolution of dynamical variables over a short period of time. Transitions between the regimes and their duration can be predicted with great accuracy by means of counting and classification strategies, for which we train multi-layer perceptron ensembles. Even for the longest regimes the occurrences and duration can be predicted. We also show the use of an echo state network to generate data of the time series with an accuracy of up to a few hundreds time steps. The ability of the classification technique to predict the regime duration of more than 11 oscillations corresponds to around 10 Lyapunov times

Episodic breathlessness: Translation and consenting of the international definition using the Delphi method

Background: Similar to pain, refractory breathlessness can occur episodically. Episodic Breathlessness is a distressing symptom in patients with advanced life-limiting disease. The lack of a universal definition impedes symptom understanding in clinical practice and effective management, respectively. The aim of the study was to formally consent a German translation of the English definition and terminology of episodic breathlessness. Methods: A web-based Delphi survey was conducted with German breathlessness experts (breathlessness working group of Germany's National Guideline (S3) for Palliative Care). Drafts of German-language definitions und terminology were assessed using structured questionnaires by binary rating or rankings, respectively. Optional comments were analysed by content analysis. Consensus was defined by >= 70 % agreement among participants. Results: In two resulting Delphi-rounds 8/16 (50 %) und 11/16 (69 %) experts, 30-59 years of age, 50 %/55 % female, participated. After the second round, consensus was reached for the symptom's description Atemnotattacke (73 %) and a German-language definition (90 %). The terms vorhersehbar vs. unvorhersehbar were directly consented for the categorization (88 %). Conclusion: The formally consented German definition and terminology of episodic breathlessness enable clearer symptom understanding and provide a precise basis for education and research on the symptom and its management also in Germany. Effective management options are warranted to improve quality of life of suffering patients and their relatives

The Role of End-of-Life Issues in the Design and Reporting of Cancer Clinical Trials: A Structured Literature Review

Background Randomized controlled trials (RCTs) are important sources of information on the benefits and harms patients may expect from treatment options. The aim of this structured literature review by the German Institute for Quality and Efficiency in Health Care was to explore whether and how the end-of-life (EoL) situation of patients with advanced cancer is considered in RCTs investigating anti-cancer treatments. Methods Our journal pool comprised 19 medical journals, namely five preselected key general medical journals as well as 14 specialist journals (mainly cancer) identified via a scoping search. We systematically searched these journals in MEDLINE to identify RCTs investigating anticancer treatments for the following four cancer types: glioblastoma, lung cancer (stage IIIb-IV), malignant melanoma (stage IV), and pancreatic cancer (search via OVID; November 2012). We selected a representative sample of 100 publications, that is, the 25 most recent publications for each cancer type. EoL was defined as a life expectancy of <= two years. We assessed the information provided on (1) the descriptions of the terminal stage of the disease, (2) the therapeutic goal (i.e. the intended therapeutic benefit of the intervention studied), (3) the study endpoints assessed, (4) the authors' concluding appraisal of the intervention's effects, and (5) the terminology referring to the patients' EoL situation. Results Median survival was <= one year for each of the four cancer types. Descriptions of the terminal stage of the disease were ambiguous or lacking in 29/100 publications. One or more therapeutic goals were mentioned in 51/100 publications; these goals were patient-relevant in 38 publications (survival alone: 30/38; health-related quality of life (HRQoL) or HRQoL and survival: 6/38; symptom control or symptom control and survival: 2/38). Primary end-points included survival (50%), surrogates (44%), and safety (3%). Patient-reported outcomes (PROs) were assessed in 36/100 RCTs. The implications of treatment-related harms for the patients were discussed in 22/100 appraisals. Terminology referring to the patients' EoL situation (e.g. terminal) was scarce, whereas terms suggesting control of the disease (e.g. cancer control) were common. Conclusions The EoL situation of patients with advanced cancer should be more carefully considered in clinical trials. Although the investigation and robust reporting of PROs is a prerequisite for informed decision-making in healthcare, they are rarely defined as endpoints and HRQoL is rarely mentioned as a therapeutic goal. Suggestions for improving standards for study design and reporting are presented